FDA Approves Siemens’ New Image Reconstruction Algorithm for CT

The U.S. Food and Drug Administration (FDA) has given 510(k) clearance for a new image reconstruction algorithm for CT developed by Siemens.

The Advanced Model Iterative Reconstruction (ADMIRE) supplements Siemens’ Sinogram Affirmed Iterative Reconstruction (SAFIRE), which is a raw-data based iterative reconstruction algorithm that can provide dose reduction of up to 60 percent, according to a release. Siemens states that image quality, which usually tends to worsen with lower dose, can result in images with a natural image impression and improved reconstructed image quality with ADMIRE.[[{"type":"media","view_mode":"media_crop","fid":"27102","attributes":{"alt":"","class":"media-image media-image-right","id":"media_crop_8598634534260","media_crop_h":"0","media_crop_image_style":"-1","media_crop_instance":"2604","media_crop_rotate":"0","media_crop_scale_h":"0","media_crop_scale_w":"0","media_crop_w":"0","media_crop_x":"0","media_crop_y":"0","style":"height: 66px; width: 100px; border-width: 0px; border-style: solid; margin: 1px; float: right;","title":" ","typeof":"foaf:Image"}}]]

ADMIRE is offered in Siemens’ SOMATOM Force, a dual-source CT system, and uses additional modeling loops that help deliver improved resolution at high contrast edges, resulting in the ability to deliver many studies at previously unachievable low-dose imaging, the release said.